PGH1, the Precursor for the Anti-Inflammatory Prostaglandins of the 1-series, Is a Potent Activator of the Pro-Inflammatory Receptor CRTH2/DP2
Open Access
- 19 March 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (3) , e33329
Abstract
Prostaglandin H1 (PGH1) is the cyclo-oxygenase metabolite of dihomo-γ-linolenic acid (DGLA) and the precursor for the 1-series of prostaglandins which are often viewed as “anti-inflammatory”. Herein we present evidence that PGH1 is a potent activator of the pro-inflammatory PGD2 receptor CRTH2, an attractive therapeutic target to treat allergic diseases such as asthma and atopic dermatitis. Non-invasive, real time dynamic mass redistribution analysis of living human CRTH2 transfectants and Ca2+ flux studies reveal that PGH1 activates CRTH2 as PGH2, PGD2 or PGD1 do. The PGH1 precursor DGLA and the other PGH1 metabolites did not display such effect. PGH1 specifically internalizes CRTH2 in stable CRTH2 transfectants as assessed by antibody feeding assays. Physiological relevance of CRTH2 ligation by PGH1 is demonstrated in several primary human hematopoietic lineages, which endogenously express CRTH2: PGH1 mediates migration of and Ca2+ flux in Th2 lymphocytes, shape change of eosinophils, and their adhesion to human pulmonary microvascular endothelial cells under physiological flow conditions. All these effects are abrogated in the presence of the CRTH2 specific antagonist TM30089. Together, our results identify PGH1 as an important lipid intermediate and novel CRTH2 agonist which may trigger CRTH2 activation in vivo in the absence of functional prostaglandin D synthase.Keywords
This publication has 80 references indexed in Scilit:
- Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndromeJournal of Lipid Research, 2010
- Endocytosis and signalling: intertwining molecular networksNature Reviews Molecular Cell Biology, 2009
- Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biologyJournal of Lipid Research, 2009
- Prostanoids in health and diseaseJournal of Lipid Research, 2009
- Cyclooxygenases: structural and functional insightsJournal of Lipid Research, 2009
- Biochemical, Functional, and Pharmacological Characterization of AT-56, an Orally Active and Selective Inhibitor of Lipocalin-type Prostaglandin D SynthaseJournal of Biological Chemistry, 2009
- CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Δ12-Prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytesProstaglandins & Other Lipid Mediators, 2005
- Effect of supplementation with 20:3(n − 6), 20:4(n − 6) and 20:5(n − 3) on the production of prostaglandins E and F of the 1-, 2- and 3-series in turbot (Scophthalmus maximus) brain astroglial cells in primary cultureBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994